Results for carcinogenicity translation from Portuguese to English

carcinogenicity testing
carcinogenicity testing

ocde (2002). guidance notes for analysis and evaluation of chronic toxicity and carcinogenicity studies.
oecd (2002).

carcinogenicity testing pre- authorisation studies to assess the potential for resistance resulting from the use of antimicrobial veterinary medicinal products
carcinogenicity testing pre-authorisation studies to assess the potential for resistance resulting from the use of antimicrobial veterinary medicinal products

note for guidance on photosafety testing note for guidance on specification limits for residues of metal catalysts swp conclusions and recommendations with regard to the use of genetically modified animal models for carcinogenicity assessment
swp conclusions and recommendations with regard to the use of genetically modified animal models for carcinogenicity assessment

guidance document on the design and conduct of chronic toxicity and carcinogenicity studies, supporting test guidelines 451, 452 and 453 — segunda edição.
guidance document on the design and conduct of chronic toxicity and carcinogenicity studies, supporting test guidelines 451, 452 and 453 — second edition.

título points to consider on the need for assessment of reproductive toxicity of human insulin analogues concept paper on the development of a cpmp position paper on the non-clinical safety studies to support low dose clinical screening studies in humans position paper on the non-clinical safety studies to support clinical trials with a single low dose of a compound note for guidance on photosafety testing note for guidance on specification limits for residues of metal catalysts swp conclusions and recommendations with regard to the use of genetically modified animal models for carcinogenicity assessment note for guidance on carcinogenic potentialnote for guidance on comparability of medicinal products containing biotechnology-derived proteins as drug substance:
cpmp/swp/5199/02points to consider on the need for assessment of reproductive toxicity of human insulin analogues concept paper on the development of a cpmp position paper on the non-clinical safety studies to support low dose clinical screening studies in humans note for guidance on photosafety testing swp conclusions and recommendations with regard to the use of genetically modified animal models for carcinogenicity assessment note for guidance on carcinogenic potential position paper on the non-clinical safety studies to support clinical trials with a single low dose of a compound note for guidance on specification limits for residues of metal catalysts note for guidance on comparability of medicinal products containing biotechnology-derived proteins as drug substance: